Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Chatonnet

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Nature Neuroscience|December 26, 2001
Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryoMartine Behra, Xavier Cousin, Christelle Bertrand, et al.
Chemico-Biological Interactions|June 14, 2008
Genetic ablation of acetylcholinesterase alters muscle function in miceAlban Vignaud, Françoise Fougerousse, Etienne Mouisel, et al.
Journal of Medicinal Chemistry|June 21, 2021
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse ModelMatthias Scheiner, Matthias Hoffmann, Feng He, et al.
CNS Neuroscience & Therapeutics|June 18, 2024
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's diseaseAllison Carles, Matthias Hoffmann, Matthias Scheiner, et al.
Muscle & Nerve|March 21, 2012
Effect of locomotor training on muscle performance in the context of nerve-muscle communication dysfunctionWahiba Hadj-Saïd, Marie Bangratz, Alban Vignaud, et al.
American Journal of Human Genetics|October 18, 2003
Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementiaMichael A Simpson, Harold Cross, Christos Proukakis, et al.
The FEBS Journal|February 19, 2008
Acetylcholinesterase from the invertebrate Ciona intestinalis is capable of assembling into asymmetric forms when co-expressed with vertebrate collagenic tail peptideAdam Frederick, Igor Tsigelny, Frances Cohenour, et al.
Neurogenetics|February 16, 2005
A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegiaJohanna A Reed, Phillip A Wilkinson, Heema Patel, et al.
European Journal of Medicinal Chemistry|January 17, 2026
Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse modelKora Reichau, Lucie Crouzier, Tina Gehrig, et al.
Chemico-Biological Interactions|November 8, 2025
Sex-specific aggressive and emotional behavior in myostatin-deficient mice: Ratio of acylated versus unacylated ghrelin is reduced, but not correlated with butyrylcholinesterase activity level, however parvalbumin expression is lost in the habenular complexBarbara Vernus, Bénédicte Goustard, Béatrice Chabi, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Nature Neuroscience|December 26, 2001
Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryoMartine Behra, Xavier Cousin, Christelle Bertrand, et al.
Chemico-Biological Interactions|June 14, 2008
Genetic ablation of acetylcholinesterase alters muscle function in miceAlban Vignaud, Françoise Fougerousse, Etienne Mouisel, et al.
Journal of Medicinal Chemistry|June 21, 2021
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse ModelMatthias Scheiner, Matthias Hoffmann, Feng He, et al.
CNS Neuroscience & Therapeutics|June 18, 2024
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's diseaseAllison Carles, Matthias Hoffmann, Matthias Scheiner, et al.
Muscle & Nerve|March 21, 2012
Effect of locomotor training on muscle performance in the context of nerve-muscle communication dysfunctionWahiba Hadj-Saïd, Marie Bangratz, Alban Vignaud, et al.
American Journal of Human Genetics|October 18, 2003
Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementiaMichael A Simpson, Harold Cross, Christos Proukakis, et al.
The FEBS Journal|February 19, 2008
Acetylcholinesterase from the invertebrate Ciona intestinalis is capable of assembling into asymmetric forms when co-expressed with vertebrate collagenic tail peptideAdam Frederick, Igor Tsigelny, Frances Cohenour, et al.
Neurogenetics|February 16, 2005
A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegiaJohanna A Reed, Phillip A Wilkinson, Heema Patel, et al.
European Journal of Medicinal Chemistry|January 17, 2026
Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an Alzheimer's disease mouse modelKora Reichau, Lucie Crouzier, Tina Gehrig, et al.
Chemico-Biological Interactions|November 8, 2025
Sex-specific aggressive and emotional behavior in myostatin-deficient mice: Ratio of acylated versus unacylated ghrelin is reduced, but not correlated with butyrylcholinesterase activity level, however parvalbumin expression is lost in the habenular complexBarbara Vernus, Bénédicte Goustard, Béatrice Chabi, et al.
Pageof 5